Neurocrine Bioscience buy Cantor Fitzgerald
Start price
24.10.23
/
50%
€102.55
Target price
24.10.24
-
Performance (%)
24.87%
Price
20.05.24
€130.10
Summary
This prediction is currently active. The prediction currently has a performance of 24.87%. This prediction currently runs until 24.10.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Neurocrine Bioscience | 3.131% | 3.131% |
iShares Core DAX® | 0.051% | 5.593% |
iShares Nasdaq 100 | 1.808% | 7.445% |
iShares Nikkei 225® | 2.181% | 2.815% |
iShares S&P 500 | 1.040% | 4.975% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€129.55
10.04.24
10.04.24
€144.01
10.04.25
10.04.25
0.42%
20.05.24
20.05.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.25
13.09.23
13.09.23
€126.70
13.09.24
13.09.24
21.31%
20.05.24
20.05.24